The Epigenomics of Common Disease
Project Leader: Christopher Bell
Genome-wide association studies (GWAS) have identified many variations but their effect sizes are modest and the majority of causality remains unexplained for most common diseases. The aim of this project is to integrate GWAS with epigenome-wide association studies (EWAS) to gain a more complete picture of the aetiology of common diseases, including T1D, T2D and UC.
The Epigenomics of Common Disease
1) Type II Diabetes (DEEP Consortium)
2) Type I Diabetes Nephropathy
Reference List
Collaborators
DEEP Consortium
Project Leader

Christopher Bell, MB ChB, PhD, FRCPA
Medical Genomics
UCL Cancer Institute
University College London
Paul O’Gorman Building
72 Huntley Street
London WC1E 6BT, UK
Tel: +44-20-7679-0963
christopher.bell@ucl.ac.uk

